UZEDY
LIVE

Serial Number

79456733

Owner

Teva Pharmaceuticals International GmbH

Filing Date

May 27, 2026

Add to watchlist:

No watchlists yet
View on USPTO

UZEDY Trademark

Serial Number: 79456733

UZEDY is a trademark filed by Teva Pharmaceuticals International GmbH on May 27, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Teva Pharmaceuticals International GmbH (109 trademarks)

Schlüsselstrasse 12

Entity Type: 98

Trademark Details

Filing Date

May 27, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the prevention and treatment of alzheimer's disease; pharmaceutical preparations for the prevention and treatment of depression; pharmaceutical preparations for the prevention and treatment of psychological disorders; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of osteoporosis; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; pharmaceutical preparations for the prevention and treatment of aids-related disorders; pharmaceutical preparations that support, encourage and promote bone strength; pharmaceutical preparations that support, encourage and promote bone health; pharmaceutical preparations used in the treatment of bone disorders and bone diseases; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, fertility enhancement preparations; pharmaceutical preparations, namely, hormone replacement therapy preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical agents affecting the central nervous system; pharmaceutical agents affecting circulatory systems; pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting urogenital organs; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of neurological disorders.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 26, 2026 RFCR
NON-FINAL ACTION WRITTEN
Sep 25, 2026 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 24, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 20, 2026 REPR